Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,264,635 papers from all fields of science
Search
Sign In
Create Free Account
Prajmaline
Known as:
Ajmalanium, 17,21-dihydroxy-4-propyl-, (17R,21alpha)-
, N-Propylajmaline
, Prajmaline [Chemical/Ingredient]
Expand
A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Broader (1)
Anti-Arrhythmia Agents
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Narrower (2)
Neo-Gilurytmal
Prajmalium Bitartrate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Comparative Analysis of the Action of Class I Antiarrhythmic Drugs (Lidocaine, Quinidine, and Prajmaline) in Rabbit Atrial and Ventricular Myocardium
H. Langenfeld
,
J. Weirich
,
Christian Köhler
,
K. Kochsiek
Journal of Cardiovascular Pharmacology
1990
Corpus ID: 34584305
Effects of three class I antiarrhythmic drugs (quinidine, lidocaine, and prajmaline) on transmembrane resting (RMP) and action…
Expand
1985
1985
Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation
C. Zekorn
,
G. Achtert
,
H. Hausleiter
,
C. Moon
,
M. Eichelbaum
Klinische Wochenschrift
1985
Corpus ID: 1425893
SummaryIn order to determine whether the metabolism of the antiarrhythmic drug N-propylajmaline is under the same genetic control…
Expand
1983
1983
Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
B. Schwartzkopff
,
G. Schilling
,
H. Simon
Arzneimittel-Forschung
1983
Corpus ID: 19576091
The antiarrhythmic efficacy of tocainide, a new antiarrhythmic substance, has been compared with that of prajmalium bitartrate, a…
Expand
1981
1981
Evaluation of prajmalium-induced cholestasis by immunologic tests.
H. Rotmensch
,
A. Leiser
,
+6 authors
M. Liron
Archives of Internal Medicine
1981
Corpus ID: 38149775
Cholestatic jaundice developed in four patients after the administration of prajmalium bitartrate. The clinical, histologic…
Expand
1981
1981
Experience with immunological tests in drug-induced hepatitis.
H. Rotmensch
,
M. Weintraub
,
G. Sofferman
,
E. Livni
,
A. Klejman
,
M. Liron
Zeitschrift für Gastroenterologie - German…
1981
Corpus ID: 21264673
Nine patients are reported who developed hepatic injury following the administration of therapeutic agents. The drugs…
Expand
1978
1978
Pharmacokinetic studies of the antiarrhythmic drugs ajmaline and N-propylajmaline bitartrate in dogs.
M. Anttila
,
R. Tikkanen
,
L. Nieminen
Arzneimittel-Forschung
1978
Corpus ID: 37145727
A rapid, sensitive fluorometric method for the determination of ajmaline and N-propylajmaline (NPA) was used to follow serum…
Expand
1978
1978
[Oral prajmalium bitartrate and intravenous lidocaine in the control of arrhythmias in acute myocardial infarction (author's transl)].
W. Bussmann
,
S. Schreiber
,
M. Kaltenbach
Deutsche Medizinische Wochenschrift
1978
Corpus ID: 40900237
1976
1976
[Prajmalium bitartrat-induced liver damage (author's transl)].
H. Lindner
,
D. Weber
,
G. Klöppel
Deutsche Medizinische Wochenschrift
1976
Corpus ID: 42551132
Liver damage was found in five patients (three men, two women) who were receiving prajmalium bitartrate. The cause was proven by…
Expand
1976
1976
[Effect of prajmalium bitartrate and procaine amide on ventricular extrasystoles (author's transl)].
W. Bussmann
,
E. Müller
,
M. Kaltenbach
Deutsche Medizinische Wochenschrift
1976
Corpus ID: 7349292
Prajmalium bitartrate (Neo-Gilurytmal) was given to 19 patients, who had either runs of ventricular extrasystoles or frequent…
Expand
1976
1976
[Intrahepatic cholestasis caused by prajmalium bitartrate].
H. Pantlen
Deutsche Medizinische Wochenschrift
1976
Corpus ID: 45947886
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE